GRANT SUBMISSION Northern Sunrise County. Submitted to: Peter Thomas, CAO
|
|
- Chloe Clementine Robinson
- 5 years ago
- Views:
Transcription
1 GRANT SUBMISSION Northern Sunrise County Submitted to: Peter Thomas, CAO January 2016
2 Contents 1. PROJECT OVERVIEW ABOUT THE CAUSE What is HBOC syndrome? What can be done? How common is HBOC syndrome? PROJECT DETAILS Background ABOUT THE SOCIETY EXECUTION BENEFIT TO THE DONOR THE FUTURE SUCCESS INDICATORS MORE INFORMATION... 6
3 1. PROJECT OVERVIEW The HBOC Society is seeking financial support for a national awareness program entitled, "Risky Genes", which is aimed at: finding the many thousands of people that do not yet know they are at high risk for hereditary cancer to provide them with the tools they need to save their lives; providing a framework for existing hereditary breast and ovarian cancer (HBOC) syndrome carriers to become connected; garnering public support for new and existing programs specifically targeted to hereditary breast, ovarian and the other cancers HBOC syndrome carriers are susceptible to; and, ensuring prospective and confirmed HBOC syndrome carriers have adequate insurance coverage and financial management practices in place. The total cost of a national awareness program as described above is not possible to calculate at this time because the issue of hereditary cancer and the many steps required to be taken to achieve the above goals are multi-faceted and far-reaching. The HBOC Society is operating in steps, as funds become available for this purpose. The grant funding amount at the discretion of the donor. 2. ABOUT THE CAUSE 2.1. What is HBOC syndrome? HBOC syndrome is a proven inherited genetic mutation that greatly reduces one s ability to ward off or fight breast, ovarian and prostate cancer OR where there is a very strong family history of these cancers potentially due to a genetic mutation that has not been discovered yet. HBOC syndrome is used synonymously with hereditary, high risk or 'risky genes' when referring to this condition. It is well proven that the HBOC syndrome carrier population face cancer risks that are exponentially higher than in the general population. Not only is cancer is diagnosed much more often, but at a younger age and it tends to be more aggressive, which makes it harder to treat. Both men and women can carry and pass down HBOC syndrome to their children, who have a 50% chance of also being a carrier.
4 Hereditary breast cancer was first discovered in 1995 when the BRCA (breast cancer) 1 and BRCA2 genes were identified. Since the HBOC Society was formed in 2002, research has proven that mutated BRCA genes also cause a high rate of ovarian and prostate cancer, and some other cancers at lower rates. As well, many additional genes have been and will continue to be discovered that also fall under the HBOC syndrome umbrella. However, because the science is so new, only BRCA genes are the subject of most available research to date. Hereditary cancer is diagnosed at a much higher rate, younger age and tends to be more aggressive than spontaneous cancer When cancer is diagnosed in an HBOC syndrome carrier it is more likely to happen at a younger age when a person is still single or dealing with a young family, well before most people have thoughts of life insurance or financial planning, adding the stress of extreme financial difficulty at a time when least able to cope. This adds to the urgency of providing knowledge and support to those affected. Due to the nature of HBOC syndrome, many affected families have experienced illness and/or loss of multiple loved ones, including a disproportionate amount of young mothers. This leaves remaining children and blood relatives not only deeply traumatized, but intensely afraid for themselves What can be done? For those aware of their genetic status, there are options in place to avoid a cancer diagnosis or to find cancer early, when it's most treatable: increased screening for breast and ovarian cancer from age 25 increased screening for prostate cancer from age 40 chemoprevention drugs preventative surgeries: o double-mastectomy with or without reconstruction, and/or; o salpingo-oopherectomy (ovary and fallopian tube removal), sometimes in conjunction with hysterectomy and removal of top of cervix. Although drastic, the current preventative recommendations have been proven to reduce risk up to 95%, which takes carriers below general population risk. 2
5 Preventative surgeries are often recommended at an early age, between the ages of 25 to 40. All current prevention options result in additional issues, including but not limited to: relational, fertility and body-image difficulties, and; sexual dysfunction and other menopausal symptoms (known to be more intense when menopause is surgically induced) that require additional support, education and services. To date, hereditary prostate cancer remains virtually unknown. There are no prevention options in place, but early screening recommendations are in place How common is HBOC syndrome? An estimated 5-10% of all breast cancer and 10-15% of all ovarian cancer is estimated to be hereditary. Males are also susceptible to hereditary breast cancer, but at a lower rate than females. At least 5-10% of all prostate cancer is estimated to be hereditary. These percentages, widely accepted by the larger cancer organizations and the medical community, translate to 250,000 to 450,000 Canadian HBOC syndrome carriers that have been or will be diagnosed with, breast, ovarian or prostate cancer. This does not include any of the other cancers that carriers are susceptible to, nor does it include the percentage of carriers that won t develop cancer, which drives the actual number of carriers higher. HBOC syndrome affects 3-5 times more Canadians than multiple sclerosis HBOC syndrome is far more common that most people realize. Unfortunately, the media, larger cancer organizations and even some medical professionals downplay the incidence, as was often the case regarding actress Angelina Jolie Pitt s BRCA1 status. This has created widespread misperception that HBOC syndrome is only a small problem, which has detrimentally affected the ability to garner financial support for this cause. The Canadian HBOC syndrome population is estimated between 280,000 to 500, ABOUT THE SOCIETY Mission: To represent, educate and support individuals, families and communities affected by HBOC syndrome Our Vision: We believe that those individuals and families impacted by the HBOC syndrome should have timely access to quality health information and services. We believe and respect that each individual has the right to choose their own path to well-being We believe in the value of support while respecting the privacy of individuals and their families affected by the HBOC syndrome. Other organizations deal only with a part of the picture, i.e. just breast cancer, and often focus very little on their hereditary component. There are no other organizations in Canada that attempt to deal with all aspects of what it means to be an HBOC syndrome carrier. Those involved with the Society have lost grandparents, mothers, fathers, sisters, brothers, aunts, uncles, nephews, nieces, cousins and even our own children. Research has shown the subsequent generations are being diagnosed with cancer at an earlier age. We have no time to lose. The HBOC Society is very different from other cancer organizations. Because our target group has the ability to avoid a cancer diagnosis, our efforts are primarily about prevention. Other organizations are focused on afterdiagnosis. The Society and the cause need champions Because the Society is primarily about prevention, the types of companies that are normally targeted for funding by a cancer-related organization have nothing to gain, so are not interested, an obvious example being 3
6 pharmaceuticals. In addition, the larger cancer organizations themselves purport to want to eradicate cancer, but despite having at their fingertips a group in which that goal could be realized, they are not focused on their hereditary component because it represents a relatively small portion, preferring instead to direct funds towards services and research for the larger, spontaneous cancer, group. This leaves the cause and the Society in a very difficult situation. 4. PROJECT DETAILS 4.1. Background Awareness is so low that an estimated 80% of HBOC syndrome carriers are still not yet aware of their genetic status, so can do nothing to protect themselves Actress Angelina Jolie-Pitt's reveal regarding her genetic status and preventative surgeries did increase public awareness of hereditary breast and ovarian cancer somewhat, but research has shown education is still sorely lacking. Most of the HBOC carrier population still remain unaware of their genetic status, so unable to do anything to save their lives. Lack of awareness has caused an extreme funding shortfall Public knowledge and opinion drives funding decisions. Without pressure from the HBOC syndrome carrier population and their supporters, funding for the hereditary component of breast, ovarian and prostate cancer out of the larger cancer organizations has been minimal, if not entirely absent. As a result, services, resources and research are limited and fragmented. In turn, the marked lack of research has meant no targeted therapies for the carrier population's aggressive cancers and no research efforts at the genetic level to prevent cancer in the first place. Lack of awareness has also affected priorities within the health care system. Wait times for genetic testing are very long, up to two years in some regions, and the wait to obtain breast reconstruction surgery has been recently reported as high as several years. Popular opinion is still largely unsupportive of the drastic measures HBOC carriers need to take to save their lives Public lack of information and/or misinformation affects popular opinion and the people that surround HBOC syndrome carriers. Without the knowledge of where to turn for help and connection after being confirmed as an HBOC syndrome carrier, young carriers are often forced to make extreme life-changing decisions on their own, sometimes even without the support of their own loved ones. The weight of disapproval regarding prevention options may be too overwhelming and may have a detrimental effect on a carrier's decision-making, especially when facing such drastic, life-changing prevention options. Hereditary cancer can be beaten HBOC syndrome carriers are the only population that have the opportunity to actually get ahead of a cancer diagnosis. 4
7 5. EXECUTION The level of overall funding obtained will determine the ultimate scope of the project. The HBOC Society has laid the ground work for the Risky Genes Awareness Program. To date the following steps have been achieved: Branding Foundational messaging Informational website ( Official program launch at the HBOC Society annual OUR GENES conference, September 2016 Local news coverage Targeted social media Next steps and estimated costs: Develop a provincial/national media strategy ($2,500 - $5,000) Assemble visual (commercials) and print media ($5,000 - $25,000) Delivery: o Social media ($1,000 - $,5000) o Newspapers, magazines ($10,000 - $50,000) o TV / radio (up to $100,000) 6. BENEFIT TO THE DONOR The Risky Genes Awareness Program would save countless lives, so be of remarkable benefit to the HBOC syndrome population, as outlined in this submission. Benefits to the Donor include (dependent on funding level, negotiable): Website recognition Social media recognition Promotional material recognition Other media recognition The knowledge that you are making a marked difference for a cause that affects up to 1/2 million Canadians and their loved ones Other benefits to be negotiated 7. THE FUTURE Assuming funding success, HBOC syndrome carriers would receive the opportunity to live long and full lives. Increased public awareness would put pressure on government and other cancer organizations to fund their hereditary component at a proportionate level, which in turn would result in increased research, providing hope for future generations. 5
8 The HBOC Society would continue to benefit through increased volunteerism and financial support, allowing expansion of their programs and services. 8. SUCCESS INDICATORS Primary success indicators are measurable through in-house and public-access records: Media uptake Increased genetic testing uptake Increased high risk clinic visit uptake Increased preventative measure uptake. Increased HBOC Society contacts Increased volunteerism and financial support for the Society and the cause Increased funds coming out of the larger cancer organizations for their hereditary component Decreased hereditary breast, ovarian and prostate cancer diagnoses and deaths Secondary indicators, although less tangibly measured, will be obvious to the carrier population: Increased public support for the HBOC syndrome carrier's plight and choices. Increased knowledge and emotional support from within the medical community. Increased emotional support from within carrier peer groups and families. 9. MORE INFORMATION Mary McDonald, Chief Executive Officer E. P C
9 #114, Kingsway Ave. Edmonton, Alberta T5G 0X5 Ph: Toll Free: HBOC (4262) Charitable Registration # RR
patient education Fact Sheet
patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations OCTOBER 2017 BRCA1 and BRCA2 Mutations Cancer is caused by several different factors. A few types of cancer run in families. These types are
More informationUnderstanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious
Understanding Your Genetic Test Result Positive for a Deleterious Mutation or Suspected Deleterious This workbook is designed to help you understand the results of your genetic test and is best reviewed
More informationThis information explains the advice about familial breast cancer (breast cancer in the family) that is set out in NICE guideline CG164.
Familial breast cancer (breast cancer in the family) Information for the public Published: 1 June 2013 nice.org.uk About this information NICE guidelines provide advice on the care and support that should
More informationUnderstanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious
Understanding Your Genetic Test Result Positive for a Deleterious Mutation or Suspected Deleterious This workbook is designed to help you understand the results of your genetic test and is best reviewed
More informationInformation leaflet for women with an increased lifetime risk of breast and ovarian cancer. Hereditary Breast and Ovarian Cancer (HBOC)
Information leaflet for women with an increased lifetime risk of breast and ovarian cancer Hereditary Breast and Ovarian Cancer (HBOC) What is Hereditary Breast and Ovarian Cancer (HBOC)? Hereditary Breast
More informationSporadic Cancer - Cancer which occurs by chance. People with sporadic cancer typically do not have relatives with the same type of cancer.
to risk assessment Hereditary Cancer Testing: Is it Right for You? This workbook is designed to help you decide if hereditary cancer testing is right for you and should be reviewed with a trained healthcare
More informationpatient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015
patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015 BRCA1 and BRCA2 Mutations Cancer is a complex disease thought to be caused by several different factors. A few types of cancer
More informationA Patient s Guide to. Hereditary Ovarian Cancer: Is Hereditary Cancer Testing Right for You?
A Patient s Guide to Hereditary Ovarian Cancer: Is Hereditary Cancer Testing Right for You? What is Hereditary Cancer? Most cancers occur in people who do not have a strong family history of that cancer.
More informationWhat Are Genes And Chromosomes?
Clinical Genetics Predictive testing for a Breast Cancer 2(BRCA2) Gene alteration Information for families where an altered cancer gene has been found and who are considering undergoing predictive testing
More informationHereditary Breast and Ovarian Cancer (HBOC) Information for individuals and families
Hereditary Breast and Ovarian Cancer (HBOC) Information for individuals and families What is Hereditary Breast and Ovarian Cancer (HBOC)? Hereditary Breast and Ovarian Cancer is a genetic condition which
More informationDoes Cancer Run in Your Family?
Does Cancer Run in Your Family? A Patient s Guide to Hereditary Breast and Ovarian Cancer Syndrome What is Hereditary Cancer? Most cancers occur in people who do not have a strong family history of that
More informationPOSITIVE DELETERIOUS MUTATION
Understanding Your Genetic Test Result Positive for a Deleterious or Suspected Deleterious POSITIVE DELETERIOUS MUTATION This workbook is designed to help you understand the results of your genetic test
More informationEligibility criteria for prophylactic treatment allowance
Eligibility criteria for prophylactic treatment allowance Southern Cross will only pay the prophylactic treatment allowance for the following healthcare services when the applicable eligibility criteria
More informationHereditary Breast and Ovarian Cancer Rebecca Sutphen, MD, FACMG
Hereditary Breast and Ovarian Cancer 2015 Rebecca Sutphen, MD, FACMG Among a consecutive series of 11,159 women requesting BRCA testing over one year, 3874 responded to a mailed survey. Most respondents
More informationBRCAnowTM It s Your Decision
Hereditary Breast and Ovarian Cancer BRCAnowTM It s Your Decision Patient & Physician Information What is BRCA? The breast cancer genes BRCA1 and BRCA2 are found within an individual s normal genetic makeup;
More informationWhat s In Your Genes: How changes in the BRCA1/BRCA2 genes
ESSENTIALS BRCA1/BRCA2 Mutations What s In Your Genes: How changes in the BRCA1/BRCA2 genes might affect you and your family Our genes contain the codes for producing the proteins that are the building
More informationCancer Survivorship Symposium Cancer and Heredity January 16, Jeanne P. Homer, MS Licensed Certified Genetic Counselor
Cancer Survivorship Symposium Cancer and Heredity January 16, 2017 Jeanne P. Homer, MS Licensed Certified Genetic Counselor Outline Cancer and Heredity Hereditary Cancer Risk Assessment & Genetic testing
More informationPrecision Medicine and Genetic Counseling : Is Yes always the correct answer?
Precision Medicine and Genetic Counseling : Is Yes always the correct answer? Beverly M. Yashar, MS, PhD, CGC Director, Graduate Program in Genetic Counseling Professor, Department of Human Genetics. (yashar@umich.edu)
More informationUtilization of BRCA Testing. Breast and Ovarian Cancer in Texas
Utilization of BRCA Testing in Older Ode Women with Breast and Ovarian Cancer in Texas Ana M. Rodriguez, MD Assistant Professor Department of Obstetrics and Gynecology University of Texas Medical Branch
More informationSo, now, that we have reviewed some basics of cancer genetics I will provide an overview of some common syndromes.
Hello. My name is Maureen Mork and I m a Certified Genetic Counselor in the Clinical Cancer Genetics Program at The University of Texas MD Anderson Cancer Center. I ll be lecturing today on the Cancer
More informationINTRODUCTION BREAST CANCER CARE
INTRODUCTION Breast Cancer Care welcomes the HFEA s consultation on embryo selection for inherited cancer. This is an extremely important and complex issue. Because of this, Breast Cancer Care has encouraged
More informationPage 1 of 5 Home > Research & Grants > Research and Scientific Programs > What is genetic testing for breast cancer and who should get it? What is genetic testing for breast cancer and who should get it?
More informationBRCA1 and BRCA2. patient guide. genetic testing for hereditary breast and ovarian cancer (hboc)
patient guide BRCA1 and BRCA2 genetic testing for hereditary breast and ovarian cancer (hboc) Because knowing your risk can mean early detection and prevention Know the Basics People with HBOC may have
More informationAdvice about familial aspects of breast cancer and epithelial ovarian cancer
Advice about familial aspects of breast cancer and epithelial ovarian cancer a guide for health professionals FEBRUARY 2006 These guidelines contain three parts: 1. Information for health professionals
More informationScreening for Genes for Hereditary Breast and Ovarian Cancer in Jewish Women
Screening for Genes for Hereditary Breast and Ovarian Cancer in Jewish Women Background About 5% of women in Canada with breast cancer and about 12% of women with ovarian cancer, are born with an inherited
More informationPlease read the following instructions carefully
Grand River Regional Cancer Centre 835 King Street West, PO Box 9056 Kitchener, ON N2G 1G3 Tel: (519) 749-4370 x2832 Fax: (519) 749-4394 Dear: You have been referred to the High Risk Ontario Breast Screening
More informationGenetic Screening Visit
Before your visit In a typical hereditary breast ovarian cancer genetic counsling visit be prepared to answer the following set of questions, please check were applicable. About your self (same questions
More informationBRCA genes and inherited breast and ovarian cancer. Information for patients
BRCA genes and inherited breast and ovarian cancer Information for patients This booklet has been written for people who have a personal or family history of breast and/or ovarian cancer that could be
More informationLori Carpenter, MS, LCGC Saint Francis Hospital
Lori Carpenter, MS, LCGC Saint Francis Hospital What is cancer genetic counseling Myth 1: Breast cancer is inevitable in my family Myth 2: My family history is on my dad s side, so it doesn t count Myth
More informationI MAY NOT HAVE ALL THE ANSWERS BUT AT LEAST I HAVE THE QUESTIONS TO GET THE PROPER. care guidelines
I MAY NOT HAVE ALL THE ANSWERS BUT AT LEAST I HAVE THE QUESTIONS TO GET THE PROPER care guidelines Hi, Being diagnosed with breast cancer is tough at any age, but being diagnosed when you re young makes
More informationGETTING A GRIP. A Report Into Breast Health Understanding Among Women In Australia
GETTING A GRIP A Report Into Breast Health Understanding Among Women In Australia Based on independent research carried out by AMR for the McGrath Foundation October 2016 FOREWORD With the sheer number
More informationInformation leaflet for for men from families with a known alteration in the BRCA1/2 gene. BRCA1 and BRCA2 for men
Information leaflet for for men from families with a known alteration in the BRCA1/2 gene BRCA1 and BRCA2 for men Introduction BRCA1 and BRCA2 are two genes which can sometimes be linked to breast, ovarian
More informationI have ovarian cancer
I have ovarian cancer Everything you need to know about BRCA1/2 gene mutations (Scotland only) 1 An introduction to BRCA1/2 gene mutations BRCA1 and BRCA2 are genes that repair damage in cells and prevent
More informationWelcome! Here s our agenda for today:
Welcome! Here s our agenda for today: What is ovarian cancer? What causes it? When does genetic testing come in? When are families at risk for ovarian cancer? What are the treatments? 3 things to remember
More informationThe benefit of. knowing. Genetic testing for hereditary cancer. A patient support guide
The benefit of knowing Genetic testing for hereditary cancer A patient support guide Does cancer run in your family? Cancer is more common in some families. Sometimes cancer is caused by a change in a
More information2018 Edition The Current Landscape of Genetic Testing
2018 Edition The Current Landscape of Genetic Testing Market growth, reimbursement trends, challenges and opportunities November April 20182017 EXECUTIVE SUMMARY Concert Genetics is a software and managed
More informationCancer Genetics Risk Assessment Program Questionnaire
We greatly appreciate you taking the time to complete this questionnaire and look forward to meeting you. Gathering this information prior to your appointment will help make your visit with us as efficient
More informationX-Plain Ovarian Cancer Reference Summary
X-Plain Ovarian Cancer Reference Summary Introduction Ovarian cancer is fairly rare. Ovarian cancer usually occurs in women who are over 50 years old and it may sometimes be hereditary. This reference
More informationpatient guide Hereditary Cancer genetic testing panels Because knowing your risk can mean early detection and prevention
patient guide Hereditary Cancer genetic testing panels Because knowing your risk can mean early detection and prevention Some of the most common cancers diagnosed are: Know the Basics breast prostate uterine
More informationLynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP)
Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP) A Patient s Guide to risk assessment Hereditary Cancer Testing: Is it Right for You? This workbook is designed to help you decide if hereditary
More informationGeneticsNow TM. A Guide to Testing Hereditary Conditions in Women & Men. Patient & Physician Information
GeneticsNow TM A Guide to Testing Hereditary Conditions in Women & Men Patient & Physician Information How can BRCA status affect your health? Everyone has BRCA1 and BRCA2 genes. However, sometimes the
More informationConference Sponsorship and Exhibition Opportunities. October 6-8, 2016, Hyatt Regency Grand Cypress, Orlando FL
Conference 2016 Sponsorship and Exhibition Opportunities October 6-8, 2016, Hyatt Regency Grand Cypress, Orlando FL Who we are FORCE was founded on the principle that no one should face hereditary cancer
More informationOvarian Cancer Causes, Risk Factors, and Prevention
Ovarian Cancer Causes, Risk Factors, and Prevention Risk Factors A risk factor is anything that affects your chance of getting a disease such as cancer. Learn more about the risk factors for ovarian cancer.
More informationPolicy and Procedure. Department: Utilization Management. SNP, CHP, MetroPlus Gold, Goldcare I&II, Market Plus, Essential, HARP
Retired Date: Page 1 of 9 1. POLICY DESCRIPTION: BRCA 1&2 Genetic Testing 2. RESPONSIBLE PARTIES: Medical Management Administration, Utilization Management, Integrated Care Management, Pharmacy, Claim
More informationAngelina Jolie Removes Breasts to Prevent Cancer
Angelina Jolie Removes Breasts to Prevent Cancer Correction: Angelina Jolie's article in the New York Times was published on May 14, not May 21. Hi there. Thanks for joining us again on As It Is. I m Kelly
More informationAngelina Jolie Removes Breasts to Prevent Cancer
Angelina Jolie Removes Breasts to Prevent Cancer Hi there. Thanks for joining us again on As It Is. I m Kelly Jean Kelly. The fate of mankind will rest in the hands of one. Ooo. Don t start. Do you recognize
More informationResult Navigator. Positive Test Result: RAD51C. After a positive test result, there can be many questions about what to do next. Navigate Your Results
Result Navigator Positive Test Result: RAD51C Positive test results identify a change, or misspelling, of DNA that is known or predicted to cause an increased risk for cancer. DNA is the blueprint of life
More informationPrimary Care Approach to Genetic Cancer Syndromes
Primary Care Approach to Genetic Cancer Syndromes Jason M. Goldman, MD, FACP FAU School of Medicine Syndromes Hereditary Breast and Ovarian Cancer (HBOC) Hereditary Nonpolyposis Colorectal Cancer (HNPCC)
More informationA Patient s Guide to Hereditary Cancer. Is Hereditary Cancer Testing Right for You?
A Patient s Guide to Hereditary Cancer Is Hereditary Cancer Testing Right for You? What is Hereditary Cancer? Most cancers occur in people who do not have a strong family history of that cancer. This is
More informationMOVEMBER FUNDED MEN S HEALTH INFORMATION RESOURCES EVALUATION BRIEF. 1 P age
MOVEMBER FUNDED MEN S HEALTH INFORMATION RESOURCES EVALUATION BRIEF 1 P age Contents 1. Purpose... 3 2. Background... 3 3. beyondblue, the national depression and anxiety initiative... 4 4. Movember funded
More informationGenetic Testing for BRCA1 and BRCA2 Genes
Genetic Testing for BRCA1 and BRCA2 Genes MP9478 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes as shown below Pre and post-test genetic counseling
More informationPolicy Specific Section: Medical Necessity and Investigational / Experimental. October 15, 1997 October 9, 2013
Medical Policy Genetic Testing for Hereditary Breast and/or Ovarian Cancer Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Laboratory/Pathology Original Policy Date:
More informationA beginner s guide to BRCA1 and BRCA2
i A beginner s guide to BRCA1 and BRCA2 A beginner s guide to BRCA1 and BRCA2 Contents Introduction 1 What does it mean to have a BRCA gene mutation? 1 Background information about the BRCA1 and BRCA2
More informationSo how much of breast and ovarian cancer is hereditary? A). 5 to 10 percent. B). 20 to 30 percent. C). 50 percent. Or D). 65 to 70 percent.
Welcome. My name is Amanda Brandt. I am one of the Cancer Genetic Counselors at the University of Texas MD Anderson Cancer Center. Today, we are going to be discussing how to identify patients at high
More informationThis is a summary of what we ll be talking about today.
Slide 1 Breast Cancer American Cancer Society Reviewed October 2015 Slide 2 What we ll be talking about How common is breast cancer? What is breast cancer? What causes it? What are the risk factors? Can
More information12: BOWEL CANCER IN FAMILIES
12: BOWEL CANCER IN FAMILIES 12.1 INTRODUCTION TO GENETICS AND INHERITANCE The human body is made up of billions of cells (such as skin cells, brain cells, nerve cells, etc). Almost every cell in the body
More informationHereditary Gynecologic Cancer
patient guide Hereditary Gynecologic Cancer genetic testing panels Because knowing your risk can mean early detection and prevention About half of the women diagnosed with uterine (endometrial) cancer
More informationNew Patient Intake Form
DEMOGRAPHIC AND CONTACT INFORMATION New Patient Intake Form Patient Name Date of Birth / / Age Gender: Primary Language Race Ethnicity Cell Phone Home Phone Work Phone Email Address Primary Care Physician
More informationOvarian Cancer. What you should know. making cancer less frightening by enlightening
Ovarian Cancer What you should know making cancer less frightening by enlightening ovarian cancer the facts Over 360 cases are diagnosed in Ireland annually It is the 6th most common cancer in women 4
More informationBRCA Precertification Information Request Form
BRCA Precertification Information Request Form Failure to complete this form in its entirety may result in the delay of review. Fax to: BRCA Precertification Department Fax number: 1-860-975-9126 Section
More informationKnow your past, protect your future.
Why do you need a Medical Family Tree? Your medical family tree records your family's health history, and can help you make informed decisions for health. In the course of creating your medical family
More informationFinding the gaps between national guidelines and patient decisions in the hereditary cancer community
Finding the gaps between national guidelines and patient decisions in the hereditary cancer community Lisa Rezende, PhD Vice President/Education FORCE: Facing Our Risk of Cancer Empowered The ABOUT Network
More informationBlue Star Sunday. Increasing Awareness About Colon Cancer. Dear Faith Community,
Blue Star Sunday Increasing Awareness About Colon Cancer Dear Faith Community, West Virginia s Cancer Coalition, Mountains of Hope, invites your faith community to participate in Colorectal Cancer Awareness
More informationApproximately 5% to 10% of breast cancer (BC) is hereditary in nature. Since. By Dawna Gilchrist, MD, FRCPC, FCCMG
By Dawna Gilchrist, MD, FRCPC, FCCMG Approximately 5% to 10% of breast cancer (BC) is hereditary in nature. Since the discovery of the genes BRCA 1 and 2 in the early 1990s, genetic counselling and testing
More informationInformation for You and Your Family
Information for You and Your Family What is Prevention? Cancer prevention is action taken to lower the chance of getting cancer. In 2017, more than 1.6 million people will be diagnosed with cancer in the
More informationThe Faces of the Opioid Crisis
The Faces of the Opioid Crisis The opioid epidemic is a national crisis In 2016, more than 63,600 Americans died from drug overdoses. On average, drug overdoses now kill 174 Americans per day. 1. Due
More informationWELCOME. Taking Care of Your Health. April 30, 8 am to noon
WELCOME Taking Care of Your Health April 30, 8 am to noon Cancer: Know Your Risk Emily Kuchinsky, MS, CGC, Certified Genetic Counselor Sporadic Cancer Lifetime Probability- Women Family Cluster Risk factors
More informationCancer Conversations
Cancer Conversations Announcer: Welcome to Cancer Conversations, a podcast series from Dana-Farber Cancer Institute. In this Episode from July 2014, Dr. Huma Rana, Clinical Director of Dana-Farber s Center
More informationPATIENT INFORMATION. (Last) (First) (Middle) (Last) (City) (State) (Zip)
PATIENT INFMATION : Address: (Last) (First) (Middle) (Last) (City) (State) (Zip) Home Phone: Cell Phone: Email address: Birth date: : Gender: When is the best time to contact you? May we email you for
More informationSeptember is Childhood Cancer Awareness Month. Advocacy Toolkit. cancer.chop.edu/cancerawareness
September is Childhood Cancer Awareness Month. Advocacy Toolkit cancer.chop.edu/cancerawareness September is Childhood Cancer Awareness Month. Make your voice heard. Dear Friend, At The Children s Hospital
More informationFAMILY EDITION IN THIS ISSUE
IN THIS ISSUE Introduction New Cerebrospinal Fluid Protein Tests Offered Genetics and Creutzfeldt-Jakob Disease Second Case of Variant CJD in Canada You Asked Us Consent Form for Donation of Biological
More informationTumorNext-HR D. patient guide. a test for ovarian cancer patients to identify hereditary and tumor-specific mutations
patient guide TumorNext-HR D a test for ovarian cancer patients to identify hereditary and tumor-specific mutations Because knowing can mean personalized treatment and management Germline vs. Tumor Testing
More informationWhat You Need to Know About Ovarian Cancer
What You Need to Know About Ovarian Cancer About Us The Rhode Island Ovarian Cancer Alliance (RIOCA) was formed in honor and memory of Jessica Morris. Jessica was diagnosed with Stage IIIC Ovarian Cancer
More informationpatient guide BreastNext genetic testing for hereditary breast cancer Because knowing your risk can mean early detection and prevention
patient guide BreastNext genetic testing for hereditary breast cancer Because knowing your risk can mean early detection and prevention Know the Basics Breast cancer is the most common cancer in women
More informationLynch Syndrome. patient guide. genetic testing for hereditary colorectal and uterine cancer
patient guide Lynch Syndrome genetic testing for hereditary colorectal and uterine cancer Because knowing your risk can mean early detection and prevention Know the Basics People with Lynch syndrome may
More informationLynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP)
Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP) A Patient s Guide to risk assessment Hereditary Cancer Testing: Is it Right for You? This workbook is designed to help you decide if hereditary
More information6/8/17. Genetics 101. Professor, College of Medicine. President & Chief Medical Officer. Hereditary Breast and Ovarian Cancer 2017
Genetics 101 Hereditary Breast and Ovarian Cancer 2017 Rebecca Sutphen, MD, FACMG Professor, College of Medicine President & Chief Medical Officer INVASIVE CANCER GENETICALLY ALTERED CELL HYPERPLASIA DYSPLASIA
More informationOvaNext. patient guide. genetic testing for hereditary breast, ovarian, and uterine cancer
patient guide OvaNext genetic testing for hereditary breast, ovarian, and uterine cancer Because knowing your risk can mean early detection and prevention About half of the women diagnosed with uterine
More informationBRCA1 & BRCA2 GeneHealth UK
BRCA1 & BRCA2 GeneHealth UK BRCA1 & BRCA2 What is hereditary breast cancer? Cancer is unfortunately very common, with 1 in 2 people developing cancer at some point in their lifetime. Breast cancer occurs
More informationBreast cancer and genetics: Angelina Jolie s double mastectomy
Page 1 of 11 VIEW ALL SITES NATIONAL LOCAL WATCH TRENDING TIM BOSMA SPADINA TRAFFIC DELAYS GAME 7 WYNNE APOLOGY LCBO NHL PLAYOFFS CANADA May 14, 20136:33 pm Breast cancer and genetics: Angelina Jolie s
More informationInheritance of Gaucher Disease
Sarah Mother of a child with Gaucher Working toward a healthy future Helping her son achieve his own dreams, too Straight Talk For Patients and Families Inheritance of Gaucher Disease Genzyme Corporation
More informationGeneHealth BRCA 1&2_ qxp_Layout 1 21/02/ :44 Page 3 BRCA1 & BRCA2 GeneHealth UK
GeneHealth BRCA 1&2_8.2.17.qxp_Layout 1 21/02/2017 16:44 Page 3 BRCA1 & BRCA2 GeneHealth UK GeneHealth BRCA 1&2_8.2.17.qxp_Layout 1 21/02/2017 16:44 Page 4 BRCA1 & BRCA2 What is hereditary breast cancer?
More informationHBOC. Jessica M. Salamone, ScM, CGC
HBOC Jessica M. Salamone, ScM, CGC Certified Genetic Counselor Director of the Cancer Risk Assessment & Genetic Counseling Program Elizabeth Wende Breast Care, LLC Elizabeth Wende Breast Care Internationally
More informationTumorNext-HR D. patient guide. a test for ovarian cancer patients to identify hereditary and tumor-specific mutations
patient guide TumorNext-HR D a test for ovarian cancer patients to identify hereditary and tumor-specific mutations Because knowing can mean personalized treatment and management Germline vs. Tumor Testing
More informationNational Fertility Preservation Register: datatabase to help cancer patients with fertility issues
National Fertility Preservation Register: datatabase to help cancer patients with fertility issues by: SUE DUNLEVY NATIONAL HEALTH REPORTER From: News Corp Australia 14 days ago April 20, 2014 8:07PM Time
More informationRisk Assessment and Risk Management
Risk Assessment and Risk Management Epworth Benign Breast Disease Symposium Dr Laura Chin-Lenn 12 November 2016 Why identify those at increased risk of breast cancer? Should I be worried? 1 Why identify
More informationUCT Conference Incoming President s Speech Delivered by UCT President Chris Phelan July 4, 2018
UCT Conference 2018 - Incoming President s Speech Delivered by UCT President Chris Phelan July 4, 2018 Change is the law of life. Those who look only to the past and present are certain to miss the future.
More informationGENETIC TESTING: WHAT DOES IT REALLY TELL YOU? Lori L. Ballinger, MS, CGC Licensed Genetic Counselor University of New Mexico Cancer Center
GENETIC TESTING: WHAT DOES IT REALLY TELL YOU? Lori L. Ballinger, MS, CGC Licensed Genetic Counselor University of New Mexico Cancer Center Definitions: DNA: The material found in our cells - the instructions
More informationBreast Cancer How to reduce your risk
Prevention Series Breast Cancer How to reduce your risk Let's Make Cancer History 1 888 939-3333 www.cancer.ca Breast Cancer How to reduce your risk Breast cancer develops in abnormal cells in the breast
More informationPROVIDER POLICIES & PROCEDURES
PROVIDER POLICIES & PROCEDURES BRCA GENETIC TESTING The purpose of this document is to assist providers enrolled in the Connecticut Medical Assistance Program (CMAP) with the information needed to support
More informationSTRATEGIC PLAN
STRATEGIC PLAN 2019-2028 3 EXECUTIVE SUMMARY Health at the center Good health changes everything. With good health, children can learn, parents can provide and neighbors can work together to build, and
More informationI have ovarian cancer
I have ovarian cancer Everything you need to know about BRCA1/2 gene mutations (NHS England only) 1 An introduction to BRCA1/2 gene mutations BRCA1 and BRCA2 are genes that repair damage in cells and prevent
More informationNagahama Institute of Bio-Science and Technology
õ  Nagahama Institute of Bio-Science and Technology y â { { y è y õ õ õ ñ Œ õ  õ õ õ à ï õ õ õ õ ï è r Œ vè à ³ õ Œ º õ Þ http://www.merckmanuals.jp/home/index.html õ KEGG DISEASE http://www.genome.jp/kegg/disease/disease_ja.html
More informationpatient guide CancerNext genetic testing for hereditary cancer Because knowing your risk can mean early detection and prevention
patient guide CancerNext genetic testing for hereditary cancer Because knowing your risk can mean early detection and prevention Know the Basics Cancer occurs in about 1 in 3 adults in their lifetime types
More informationApplies to: All Aetna plans, except Traditional Choice plans. All Innovation Health plans, except indemnity plans
BRCA Precertification Information Request Form Applies to: All Aetna plans, except Traditional Choice plans All Innovation Health plans, except indemnity plans All Health benefits and health insurance
More information--- or not, and do we need to come up with newer strategies for ovarian cancer screening.
My name is Dr. Karen Lu and I am a Professor of Gynecologic Oncology at the University of Texas MD Anderson Cancer Center. I also serve as Co-Medical Director for Clinical Cancer Genetics. I m going to
More informationA practical guide to understanding cancer
A practical guide to understanding cancer 1 Are you worried about ovarian cancer? About this leaflet Some women worry about getting ovarian cancer, sometimes because a relative has had it. This leaflet
More informationAssessment and Management of Genetic Predisposition to Breast Cancer. Dr Munaza Ahmed Consultant Clinical Geneticist 2/7/18
Assessment and Management of Genetic Predisposition to Breast Cancer Dr Munaza Ahmed Consultant Clinical Geneticist 2/7/18 Overview The role of the Cancer Genetics team NICE guidelines for Familial Breast
More informationProphylactic mastectomy, a look at the problem
www.clinicaloncology.com.ua 1 Prophylactic mastectomy, a look at the problem I.I.Smolanka, S.Y.Skliar, A.D.Loboda The National Cancer Institute, Kiev Summary: The question of the bilateral prophylactic
More informationOUR MISSION: SUPPORT, EDUCATION AND RESEARCH
OUR MISSION: SUPPORT, EDUCATION AND RESEARCH LISA S STORY Lisa Hendricks was just seven years old when her parents noticed she was limping and couldn t lay her hands flat on a table. She hadn t complained
More information